Kingworld Medicines Group Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	264.41	235.3	173.68	242.16	187.93
Trading Asset Securities	10.18	14.3	20.35	14.01	10.48
Cash & Short-Term Investments	274.59	249.6	194.03	256.17	198.41
Cash Growth	10.01%	28.64%	-24.26%	29.11%	-24.12%
Accounts Receivable	157.43	157.72	152.53	183.18	237.83
Other Receivables	10.16	39.72	79.21	48.61	37.89
Receivables	167.6	202.84	236.49	236.64	280.1
Inventory	133.29	120.22	117.63	84.76	106.74
Other Current Assets	38.27	35.11	40.47	46.75	54.41
Total Current Assets	613.74	607.77	588.62	624.32	639.66
Property, Plant & Equipment	449.8	423.71	385.72	299.89	209.94
Long-Term Investments	161.7	167.37	152.01	133.82	138.04
Goodwill	90.69	90.69	90.69	90.69	90.69
Other Intangible Assets	-	-	-	0.13	13.7
Other Long-Term Assets	126.46	126.03	120.62	114.5	121.8
Total Assets	1,442	1,416	1,338	1,263	1,214
Accounts Payable	169.98	168.32	148.66	138.79	106.1
Accrued Expenses	39.32	42.55	38	7.46	10.87
Current Portion of Long-Term Debt	265.01	225.66	191.66	271.29	229.92
Current Portion of Leases	6.8	4.36	6.37	8.01	7.58
Current Income Taxes Payable	7.37	10.86	15.38	16.51	11.9
Current Unearned Revenue	66.4	59.93	57.17	57.54	71.73
Other Current Liabilities	10.42	3.19	6.29	42.16	35.52
Total Current Liabilities	565.3	514.87	463.53	541.74	473.62
Long-Term Debt	149.38	161.95	150.47	-	-
Long-Term Leases	12.68	10.47	5.93	11.39	1.45
Long-Term Unearned Revenue	-	-	-	0.6	-
Long-Term Deferred Tax Liabilities	26.18	22.75	18.37	15.42	18.12
Total Liabilities	753.54	710.04	638.3	569.15	493.2
Common Stock	53.47	53.47	53.47	53.47	53.47
Additional Paid-In Capital	139.41	139.41	139.41	139.41	152.7
Retained Earnings	505.61	512.26	490.49	466.31	443.57
Comprehensive Income & Other	-80.78	-65.35	-64.33	-43.61	-32.84
Total Common Equity	617.7	639.79	619.03	615.58	616.9
Minority Interest	71.15	65.74	80.32	78.64	103.74
Shareholders' Equity	688.85	705.53	699.35	694.22	720.63
Total Liabilities & Equity	1,442	1,416	1,338	1,263	1,214
Total Debt	433.87	402.44	354.43	290.68	238.96
Net Cash (Debt)	-159.28	-152.84	-160.4	-34.51	-40.55
Net Cash Per Share	-0.27	-0.27	-0.27	-0.06	-0.07
Filing Date Shares Outstanding	592.46	589.6	592.45	622.5	622.5
Total Common Shares Outstanding	592.46	589.6	592.45	622.5	622.5
Working Capital	48.44	92.9	125.08	82.58	166.03
Book Value Per Share	1.04	1.09	1.04	0.99	0.99
Tangible Book Value	527.01	549.1	528.34	524.75	512.5
Tangible Book Value Per Share	0.89	0.93	0.89	0.84	0.82
Land	21.25	15.81	15.22	7.55	6.98
Buildings	195.58	271.9	24.26	24.26	24.26
Machinery	97.67	95.81	93.84	89.36	78.61
Construction In Progress	96.18	0.6	204.11	116.33	36.15
Leasehold Improvements	34.01	21.43	20.88	20.66	18.37

Source: S&P Global Market Intelligence. Standard template. Financial Sources.